DUBLIN, Apr. 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9kq6w8/global) has announced the addition of the "Global Gynecological Cancers Market 2014-2018" report to their offering.
The analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market.
The report, the Global Gynecological Cancers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gynecological Cancers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Personalized medicines have the ability to provide customized treatment to patients, based on patients' genetic and medical profiles. Biomarkers are used in predicting the patient response to a particular drug and they help in identifying the patient population set that is more likely to respond to a particular drug therapy.
Personalized medicines are increasingly being used in targeted gynecological cancer therapies. The major market players are increasingly investing in targeted agents and the development of personalized therapies. Though the treatment using personalized medicine is a new concept, advancements in the techniques will drive the growth of the Global Gynecological market.
According to the report, one of the major drivers in this market is the increase in the prevalence of gynecological cancer. This increase is due to several factors such as obesity, infertility, mutations in specific genes, early start of menstruation, and late start of menopause. The increase in the prevalence of gynecological cancer has encouraged the demand for gynecological cancer drugs.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Geographical Segmentation
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Trends and their Impact
15. Vendor Landscape
16. Key Vendor Analysis
17. Other Reports in this Series
- Becton Dickinson and Co.
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline plc.
- Merck & Co.
For more information visit http://www.researchandmarkets.com/research/9kq6w8/global
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets